Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Cancer Vaccines01:30

Cancer Vaccines

1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Mitral Valve Surgery for Rheumatic Heart Disease in Indigenous Australians: A 27-Year Cohort Study of Repair Versus Replacement Outcomes.

Heart, lung & circulation·2025
Same author

Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy.

Journal of visualized experiments : JoVE·2025
Same author

Affinity enrichment of placental extracellular vesicles from minimally processed maternal plasma with magnetic nanowires.

The Analyst·2025
Same author

Rapid and high-sensitivity screening of pregnancy complications by profiling circulating placental extracellular vesicles.

Science advances·2025
Same author

Profiling the extracellular vesicles of two human placenta-derived mesenchymal stromal cell populations.

Experimental cell research·2024
Same author

Immunoaffinity-enriched salivary small extracellular vesicles in periodontitis.

Extracellular vesicles and circulating nucleic acids·2024

相关实验视频

Updated: Mar 15, 2026

Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy
07:33

Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy

Published on: September 19, 2025

922

利用CAR-细胞外囊泡为下一代癌症免疫疗法

Sharenya Chelvaretnam1, Kol Thida Mom1, Carlos Andres Palma Henriquez1

  • 1INOVIQ Ltd., Melbourne, VIC 3168, Australia.

International journal of molecular sciences
|March 14, 2026
PubMed
概括

化学抗原受体 (CAR) 技术正在推进癌症免疫疗法. 来自CAR的细胞外囊泡 (EVs) 为向癌症治疗提供了一个新的无细胞平台,有可能提高疗效并降低毒性.

关键词:
癌症 癌症 癌症 癌症 癌症仿制性抗原受体的仿制性抗原受体细胞外囊泡中的细胞外囊泡.免疫疗法 免疫疗法

更多相关视频

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

1.5K
In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
08:02

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

3.1K

相关实验视频

Last Updated: Mar 15, 2026

Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy
07:33

Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy

Published on: September 19, 2025

922
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

1.5K
In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
08:02

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

3.1K

科学领域:

  • 免疫学 免疫学 免疫学
  • 在瘤学瘤学.
  • 生物技术是生物技术.

背景情况:

  • 癌症免疫疗法已经取得了显著的进展,特别是在嵌合式抗原受体 (CAR) 技术方面.
  • 第五代CAR被设计为向瘤抗原,并已应用于T细胞,NK细胞和巨细胞.
  • CAR-T,CAR-NK和CAR-巨细胞疗法的临床成功突显了它们的治疗潜力.

研究的目的:

  • 审查CAR衍生的细胞外囊泡 (EVs) 的治疗潜力和免疫性质.
  • 探索CAR衍生的EVs在调节抗癌免疫反应中的作用.
  • 检查CAR衍生电动汽车作为化疗的向输送车辆的应用.

主要方法:

  • 审查关于CAR技术和细胞外囊泡的当前文献.
  • 分析CAR衍生的EV与免疫系统相互作用的机制.
  • 对CAR-EV应用程序的临床前和临床数据的评估.

主要成果:

  • 来自CAR的电动汽车是一个有前途的无细胞治疗平台.
  • 这些EV可以提供抗癌介质并调节免疫反应.
  • 卡尔-EV显示了针对化学疗法剂的向输送的潜力.

结论:

  • 来自CAR的EVs代表了癌症免疫治疗中一种新且可适应的方法.
  • 它们的无细胞性质在传递方面提供了优势,并有可能降低毒性.
  • 对CAR-EV的进一步研究可能会导致增强抗瘤疗效和改善患者的治疗结果.